Table S2 from The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents

Authors :: Francesco Bertoni
Jeffrey A. Toretsky
Brian Lannutti
Anastasios Stathis
Emanuele Zucca
B. Hilda Ye
Davide Genini
Monica Testoni
Ivo Kwee
Andrea Rinaldi
Andrea Cavalli
Saravana P. Selvanathan
Garrett Graham
Giulio Sartori
Valdemar Priebe
Laura Carrassa
Katti Jessen
Sara Napoli
Luciano Cascione
Chiara Tarantelli
Eugenio Gaudio
Elaine Yee Lin Chung
Filippo Spriano
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Anti-tumor activity of YK-4-279 and TK-216 in lymphomas after 72 h of exposure. Genetic features for DLBCL cells (1,2) are also shown.

Tools